Researchers at Helmholtz Munich have discovered that common, non-harmful gut bacteria possess type III secretion systems — microscopic syringe-like structures previously thought to exist only in disease-causing pathogens like Salmonella. These molecular syringes allow bacteria to inject proteins directly into human cells, actively shaping immune responses. The team mapped over 1,000 interactions between bacterial and human proteins, revealing that the injected molecules preferentially target pathways involved in immune regulation and metabolism.
"This fundamentally changes our view of commensal bacteria," said Prof. Pascal Falter-Braun, Director of the Institute for Network Biology at Helmholtz Munich. "These non-pathogenic bacteria are not just passive residents but can actively manipulate human cells." Follow-up experiments confirmed the proteins influence key immune signaling systems including NF-κB and cytokine responses.
Critically, the researchers found that genes encoding these bacterial effector proteins are significantly enriched in the gut microbiomes of people with Crohn's disease, shifting the understanding of the microbiome-disease link from correlation to mechanism. The study, published in Nature Microbiology, was co-led by first authors Veronika Young and Bushra Dohai.